161 related articles for article (PubMed ID: 31307184)
21. Urinary exosomal miRNA signature of IgA nephropathy: a case-control study.
Shankar M; Shetty A; N S M; C G S; A K; Tennankore K
Sci Rep; 2023 Dec; 13(1):21400. PubMed ID: 38049447
[TBL] [Abstract][Full Text] [Related]
22. Noninvasive Urinary Monitoring of Progression in IgA Nephropathy.
Yang JYC; Sarwal RD; Fervenza FC; Sarwal MM; Lafayette RA
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31510053
[TBL] [Abstract][Full Text] [Related]
23. Soluble transferrin receptor in urine, a new biomarker for IgA nephropathy and Henoch-Schönlein purpura nephritis.
Delanghe SE; Speeckaert MM; Segers H; Desmet K; Vande Walle J; Laecke SV; Vanholder R; Delanghe JR
Clin Biochem; 2013 May; 46(7-8):591-7. PubMed ID: 23384534
[TBL] [Abstract][Full Text] [Related]
24. U6 can be used as a housekeeping gene for urinary sediment miRNA studies of IgA nephropathy.
Duan ZY; Cai GY; Li JJ; Bu R; Wang N; Yin P; Chen XM
Sci Rep; 2018 Jul; 8(1):10875. PubMed ID: 30022109
[TBL] [Abstract][Full Text] [Related]
25. Increased excretion of tumor necrosis factor alpha and interleukin 1 beta in urine from patients with IgA nephropathy and Schönlein-Henoch purpura.
Wu TH; Wu SC; Huang TP; Yu CL; Tsai CY
Nephron; 1996; 74(1):79-88. PubMed ID: 8883024
[TBL] [Abstract][Full Text] [Related]
26. MiR-320 promotes B cell proliferation and the production of aberrant glycosylated IgA1 in IgA nephropathy.
Li C; Shi J; Zhao Y
J Cell Biochem; 2018 Jun; 119(6):4607-4614. PubMed ID: 29266359
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-155-induced T lymphocyte subgroup drifting in IgA nephropathy.
Yang L; Zhang X; Peng W; Wei M; Qin W
Int Urol Nephrol; 2017 Feb; 49(2):353-361. PubMed ID: 27796698
[TBL] [Abstract][Full Text] [Related]
28. Blood TGF-β1 and miRNA-21-5p levels predict renal fibrosis and outcome in IgA nephropathy.
Bharti N; Agrawal V; Kamthan S; Prasad N; Agarwal V
Int Urol Nephrol; 2023 Jun; 55(6):1557-1564. PubMed ID: 36648741
[TBL] [Abstract][Full Text] [Related]
29. Clinical significance of serum and mesangial galactose-deficient IgA1 in patients with IgA nephropathy.
Wada Y; Matsumoto K; Suzuki T; Saito T; Kanazawa N; Tachibana S; Iseri K; Sugiyama M; Iyoda M; Shibata T
PLoS One; 2018; 13(11):e0206865. PubMed ID: 30388165
[TBL] [Abstract][Full Text] [Related]
30. The increased miRNA-150-5p expression of the tonsil tissue in patients with IgA nephropathy may be related to the pathogenesis of disease.
Xu Y; He Y; Hu H; Xu R; Liao Y; Dong X; Song H; Chen X; Chen J
Int Immunopharmacol; 2021 Nov; 100():108124. PubMed ID: 34600394
[TBL] [Abstract][Full Text] [Related]
31. Urine protein patterns can serve as diagnostic tools in patients with IgA nephropathy.
Haubitz M; Wittke S; Weissinger EM; Walden M; Rupprecht HD; Floege J; Haller H; Mischak H
Kidney Int; 2005 Jun; 67(6):2313-20. PubMed ID: 15882273
[TBL] [Abstract][Full Text] [Related]
32. Urinary kidney injury molecule-1 is related to pathologic involvement in IgA nephropathy with normotension, normal renal function and mild proteinuria.
Xu PC; Wei L; Shang WY; Tian SL; Gu DM; Yan TK; Lin S
BMC Nephrol; 2014 Jul; 15():107. PubMed ID: 24998891
[TBL] [Abstract][Full Text] [Related]
33. Immunohistological score of transcription factor 21 had a positive correlation with its urinary excretion and proteinuria in immunoglobulin A nephropathy.
Takahashi-Kobayashi M; Usui J; Yaguchi M; Yamazaki S; Kawamura T; Kaneko S; Seshan SV; Yamagata K
Histol Histopathol; 2021 Oct; 36(10):1093-1098. PubMed ID: 34323285
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-21-5p participates in IgA nephropathy by driving T helper cell polarization.
Xu BY; Meng SJ; Shi SF; Liu LJ; Lv JC; Zhu L; Zhang H
J Nephrol; 2020 Jun; 33(3):551-560. PubMed ID: 31863364
[TBL] [Abstract][Full Text] [Related]
35. MiR-133a/133b inhibits Treg differentiation in IgA nephropathy through targeting FOXP3.
Jin LW; Ye HY; Xu XY; Zheng Y; Chen Y
Biomed Pharmacother; 2018 May; 101():195-200. PubMed ID: 29494956
[TBL] [Abstract][Full Text] [Related]
36. Intrarenal expression of microRNAs in patients with IgA nephropathy.
Wang G; Kwan BC; Lai FM; Choi PC; Chow KM; Li PK; Szeto CC
Lab Invest; 2010 Jan; 90(1):98-103. PubMed ID: 19901913
[TBL] [Abstract][Full Text] [Related]
37. MicroRNAs in IgA nephropathy.
Szeto CC; Li PK
Nat Rev Nephrol; 2014 May; 10(5):249-56. PubMed ID: 24709842
[TBL] [Abstract][Full Text] [Related]
38. Urinary Exosomal MicroRNAs as New Noninvasive Biomarkers of IgA Nephropathy.
Li S; Hao H; Li R; Guo S
Tohoku J Exp Med; 2022 Mar; 256(3):215-223. PubMed ID: 35314529
[TBL] [Abstract][Full Text] [Related]
39. Expression of alpha5beta1 and alpha6beta1 integrins in IgA nephropathy (IgAN) with mild and severe proteinuria. An immunohistochemical study.
Wagrowska-Danilewicz M; Danilewicz M
Int Urol Nephrol; 2004; 36(1):81-7. PubMed ID: 15338682
[TBL] [Abstract][Full Text] [Related]
40. Clinical manifestations of Henoch-Schönlein purpura nephritis and IgA nephropathy: comparative analysis of data from the Japan Renal Biopsy Registry (J-RBR).
Komatsu H; Fujimoto S; Yoshikawa N; Kitamura H; Sugiyama H; Yokoyama H
Clin Exp Nephrol; 2016 Aug; 20(4):552-560. PubMed ID: 26456327
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
